Drugs / 2009-2010 Trivalent Influenza Virus Vaccine
2009-2010 Trivalent Influenza Virus Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00988143 | Oct → Dec 2009 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 2009-2010 Trivalent Influenza Virus Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00988143 ↗ |
| Modality | Vaccine | “2009-2010 Trivalent Influenza Vaccine (TIV)” NCT00988143 ↗ |
| Route | Intramuscular | “0.25 mL, Intramuscular (participants at 6 to 35 months of age - Pediatric Dose); Others 0.5 mL, Intramuscular” NCT00988143 ↗ |